DAMORA THERAPEUTICS, INC. Foreign Currency Transaction Gain (Loss), before Tax
DAMORA THERAPEUTICS, INC. (DMRA) reported Foreign Currency Transaction Gain (Loss), before Tax of $16.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-10
- DAMORA THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was $16.00K.
- DAMORA THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was $0.00.
- DAMORA THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was $3.00K, a 97.60% decline year-over-year.
- DAMORA THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$19.00K.
- DAMORA THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2025 was -$84.00K, a 566.67% decline from fiscal 2024.
- DAMORA THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was $18.00K.
- DAMORA THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$197.00K.
- DAMORA THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$1.07M, a 435.11% decline from fiscal 2021.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.00K 10-Q · filed 2026-08-10 | $16.00K 10-Q · filed 2026-08-10 | $19.00K derived: sum of 3 quarters · filed 2026-08-10 | $0.00 derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | $3.00K derived: sum of 2 quarters · filed 2026-05-12 | -$16.00K derived: sum of 3 quarters · filed 2026-05-12 | -$78.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$16.00K derived: sum of 2 quarters · filed 2026-03-19 | -$78.00K derived: sum of 3 quarters · filed 2026-08-10 | -$84.00K 10-K · filed 2026-03-19 |
| 2025-09-30 | -$19.00K 10-Q · filed 2025-11-06 | -$81.00K derived: sum of 2 quarters · filed 2026-08-10 | -$87.00K 10-Q · filed 2025-11-06 | $38.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$62.00K 10-Q · filed 2026-08-10 | -$68.00K 10-Q · filed 2026-08-10 | $57.00K derived: sum of 3 quarters · filed 2026-08-10 | -$125.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$6.00K 10-Q · filed 2026-05-12 | $119.00K derived: sum of 2 quarters · filed 2026-05-12 | -$63.00K derived: sum of 3 quarters · filed 2026-05-12 | $5.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$57.00K derived: sum of 2 quarters · filed 2026-03-19 | $11.00K derived: sum of 3 quarters · filed 2026-03-19 | $18.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | -$182.00K 10-Q · filed 2025-11-06 | -$114.00K derived: sum of 2 quarters · filed 2025-11-06 | -$107.00K 10-Q · filed 2025-11-06 | -$315.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $68.00K 10-Q · filed 2025-08-05 | $75.00K 10-Q · filed 2025-08-05 | -$133.00K derived: sum of 3 quarters · filed 2025-08-05 | -$159.00K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $7.00K 10-Q · filed 2025-05-08 | -$201.00K derived: sum of 2 quarters · filed 2025-05-08 | -$227.00K derived: sum of 3 quarters · filed 2025-05-08 | -$254.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$208.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | -$234.00K derived: sum of 2 quarters · filed 2025-03-19 | -$261.00K derived: sum of 3 quarters · filed 2025-03-19 | -$197.00K 10-K · filed 2025-03-19 |
| 2023-09-30 | -$26.00K 10-Q · filed 2024-11-01 | -$53.00K derived: sum of 2 quarters · filed 2024-11-01 | $11.00K 10-Q · filed 2024-11-01 | -$817.00K derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | -$27.00K 10-Q · filed 2024-08-12 | $37.00K 10-Q · filed 2024-08-12 | -$791.00K derived: sum of 3 quarters · filed 2024-08-12 | -$1.12M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $64.00K 10-Q · filed 2024-04-29 | -$764.00K derived: sum of 2 quarters · filed 2024-04-29 | -$1.09M derived: sum of 3 quarters · filed 2024-04-29 | -$945.00K derived: sum of 4 quarters · filed 2024-04-29 |
| 2022-12-31 | -$828.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$1.16M derived: sum of 2 quarters · filed 2024-03-08 | -$1.01M derived: sum of 3 quarters · filed 2024-03-08 | -$1.07M 10-K · filed 2024-03-08 |
| 2022-09-30 | -$329.00K 10-Q · filed 2023-11-06 | -$181.00K derived: sum of 2 quarters · filed 2023-11-06 | -$241.00K 10-Q · filed 2023-11-06 | -$212.00K derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $148.00K 10-Q · filed 2023-07-31 | $88.00K 10-Q · filed 2023-07-31 | $117.00K derived: sum of 3 quarters · filed 2023-07-31 | $325.00K derived: sum of 4 quarters · filed 2023-07-31 |
| 2022-03-31 | -$60.00K 10-Q · filed 2023-04-28 | -$31.00K derived: sum of 2 quarters · filed 2023-04-28 | $177.00K derived: sum of 3 quarters · filed 2023-04-28 | $91.00K derived: sum of 4 quarters · filed 2023-04-28 |
| 2021-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $237.00K derived: sum of 2 quarters · filed 2023-03-09 | $151.00K derived: sum of 3 quarters · filed 2023-03-09 | $319.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | $208.00K 10-Q · filed 2022-11-08 | $122.00K derived: sum of 2 quarters · filed 2022-11-08 | $290.00K 10-Q · filed 2022-11-08 | $15.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$86.00K 10-Q · filed 2022-07-29 | $82.00K 10-Q · filed 2022-07-29 | -$193.00K derived: sum of 3 quarters · filed 2022-07-29 | -$1.68M derived: sum of 4 quarters · filed 2022-07-29 |
| 2021-03-31 | $168.00K 10-Q · filed 2022-04-29 | -$107.00K derived: sum of 2 quarters · filed 2022-04-29 | -$1.59M derived: sum of 3 quarters · filed 2022-04-29 | -$1.19M derived: sum of 4 quarters · filed 2022-04-29 |
| 2020-12-31 | -$275.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | -$1.76M derived: sum of 2 quarters · filed 2022-02-17 | -$1.36M derived: sum of 3 quarters · filed 2022-02-17 | -$1.20M 10-K · filed 2022-02-17 |
| 2020-09-30 | -$1.49M 10-Q · filed 2021-11-04 | -$1.08M derived: sum of 2 quarters · filed 2021-11-04 | -$925.00K 10-Q · filed 2021-11-04 | -$1.04M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $403.00K 10-Q · filed 2021-08-05 | $559.00K 10-Q · filed 2021-08-05 | $441.00K derived: sum of 3 quarters · filed 2021-08-05 | $778.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $156.00K 10-Q · filed 2021-05-04 | $38.00K derived: sum of 2 quarters · filed 2021-05-04 | $375.00K derived: sum of 3 quarters · filed 2021-05-04 | |
| 2019-12-31 | -$118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $219.00K derived: sum of 2 quarters · filed 2021-03-29 | $551.00K 10-K · filed 2021-03-29 | |
| 2019-09-30 | $337.00K 10-Q · filed 2020-12-11 | $669.00K 10-Q · filed 2020-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |